Press "Enter" to skip to content

New patent expiration for Msd Sub drug ISENTRESS

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for ISENTRESS
Annual Drug Patent Expirations for ISENTRESS

Isentress is a drug marketed by Msd Sub Merck and is included in three NDAs. It is available from nine suppliers. There are six patents protecting this drug and one Paragraph IV challenge.

ISENTRESS drug price trends.

This drug has thirty patent family members in sixteen countries.

The generic ingredient in ISENTRESS is raltegravir potassium. Nine suppliers are listed for this compound. Additional details are available on the raltegravir potassium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

    Leave a Reply

    DrugPatentWatch - Make Better Decisions